目的观察探讨联合用药对胃溃疡患者的临床治疗效果,为临床治疗该病提供更多可靠参考。方法选取我院收治的160例胃溃疡患者,将其分为观察组和对照组(每组80例),对照组患者给予阿莫西林、奥美拉唑治疗,观察组在此基础上给予克拉霉素治疗,最后对两组患者的临床疗效进行比较分析。结果治疗后,对照组显效25例,有效36例,无效19例;观察组显效39例,有效37例,无效4例,在总有效率方面,观察组(95.00%)明显优于对照组(76.25%),两组差异显著具有统计学意义(P<0.05);对照组不良反应发生率为3.75%,观察组为2.50%,两组差异无统计学意义(P>0.05)。结论阿莫西林、奥美拉唑联合克拉霉素治疗胃溃疡具有更好的疗效,不仅减轻患者痛苦,提高患者生命质量,而且安全性高,值得临床大力推广。 Objective To investigate the clinical effects of combination therapy on patients with gastric ulcer and provide more reliable references for clinical treatment of the disease. Methods 160 patients with gastric ulcer admitted to our hospital were divided into observation group and control group (80 cases in each group), patients in control group were treated with amoxicillin and omeprazole, and the observation group was given carat Mycophenolate treatment, and finally the clinical efficacy of two groups were compared. Results In the control group, 25 cases were markedly effective, 36 cases were effective and 19 cases were ineffective. In the observation group, 39 cases were markedly effective, 37 cases were effective and 4 cases were ineffective. The total effective rate was significantly higher in the observation group (95.00%) than in the control group 76.25% respectively). The difference between the two groups was statistically significant (P <0.05). The incidence of adverse reactions in the control group was 3.75% and in the observation group was 2.50%. There was no significant difference between the two groups (P> 0.05). Conclusion Amoxicillin and omeprazole combined with clarithromycin in the treatment of gastric ulcer has a better curative effect, which not only reduces the pain of patients and improves the quality of life of patients, but also has high safety and worthy of clinical promotion.